X0306 4 2017-11-15 0 0001460329 Cogint, Inc. COGT 0000898860 FROST PHILLIP MD ET AL 4400 BISCAYNE BOULEVARD MIAMI FL 33137 1 0 1 0 0001380896 Frost Gamma Investments Trust 4400 BISCAYNE BOULEVARD, 15TH FLOOR MIAMI FL 33137 0 0 1 1 Joint Filer Common Stock 2017-11-15 4 P 0 20000 4.11 A 15724874 I By Frost Gamma InvestmentsTrust Common Stock 3000000 I By Frost Gamma Investments Trust Common Stock 33333 D Common Stock 16667 D The shares were purchased in multiple transactions at prices ranging from $4.00 to $4.20, with a weighted average price per share of $4.11. The reporting person undertakes to provide Cogint, Inc., any security holder of Cogint, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price with the ranges set forth in this footnote. These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. On December 8, 2015, the reporting person received a grant, subject to stockholder approval, of 3,000,000 RSUs, convertible into common stock of the issuer on a one-for-one basis. Stockholder approval was obtained on June 1, 2016. The reporting person has elected to defer delivery of any vested RSUs until the reporting person's separation from service from the Company, a Change of Control of the Company, or death or disability. Represents Restricted Stock Units (RSUs) convertible into common stock of the issuer on a one-for-one basis. The RSUs vest in approximate equal installments on June 1, 2018 and 2019, subject to accelerated vesting under certain circumstances. Phillip Frost, M.D., Individually 2017-11-16 /s/ Phillip Frost, M.D., as Trustee 2017-11-16